Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bria

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
ESMO Open|February 3, 2026
Impact of ECOG performance status 2 participants on outcomes of pivotal cancer clinical trials: a meta-analysis and meta-regressionG M Iannantuono, T Giovagnoli, L Mastrantoni, et al.
ESMO Open|December 24, 2021
Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunitiesM Simbolo, G Centonze, G Ali, et al.
ESMO Open|August 30, 2025
Network analysis of NRG1 variants of uncertain significance (VUSes) in advanced non-small-cell lung cancer and their prognostic role in EGFR-mutant patients treated with first-line osimertinibE Vita, A Scala, A Vitale, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 23, 2017
Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter surveyS Carnio, D Galetta, V Scotti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 24, 2016
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysisA Nottegar, N Veronese, M Senthil, et al.
ESMO Open|October 25, 2025
COMPEL: osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC and progression on first-line osimertinibN Peled, A Tufman, L V Sequist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2010
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conferenceF Roila, J Herrstedt, M Aapro, et al.
ESMO Open|August 30, 2024
MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS databaseM L Reale, F Passiglia, F Cappuzzo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 21, 2019
Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective studyE Gobbini, R Chiari, P Pizzutillo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 9, 2019
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudesA Cortellini, A Leonetti, A Catino, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
ESMO Open|February 3, 2026
Impact of ECOG performance status 2 participants on outcomes of pivotal cancer clinical trials: a meta-analysis and meta-regressionG M Iannantuono, T Giovagnoli, L Mastrantoni, et al.
ESMO Open|December 24, 2021
Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunitiesM Simbolo, G Centonze, G Ali, et al.
ESMO Open|August 30, 2025
Network analysis of NRG1 variants of uncertain significance (VUSes) in advanced non-small-cell lung cancer and their prognostic role in EGFR-mutant patients treated with first-line osimertinibE Vita, A Scala, A Vitale, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 23, 2017
Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter surveyS Carnio, D Galetta, V Scotti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 24, 2016
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysisA Nottegar, N Veronese, M Senthil, et al.
ESMO Open|October 25, 2025
COMPEL: osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC and progression on first-line osimertinibN Peled, A Tufman, L V Sequist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2010
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conferenceF Roila, J Herrstedt, M Aapro, et al.
ESMO Open|August 30, 2024
MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS databaseM L Reale, F Passiglia, F Cappuzzo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 21, 2019
Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective studyE Gobbini, R Chiari, P Pizzutillo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 9, 2019
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudesA Cortellini, A Leonetti, A Catino, et al.
Pageof 6